Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin vs Flibanserin + Sex Therapy for HSDD
NCT02714049Phase 4Terminated
- Sponsor
- San Diego Sexual Medicine
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of flibanserin in hypoactive sexual desire disorder (HSDD), sponsored by San Diego Sexual Medicine. Started Jan 2017; status: terminated.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT02714049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714049.